49 results
8-K
EX-10.1
HEPA
Hepion Pharmaceuticals Inc
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
one member of the Board of Directors qualifies as a “financial expert” as such term is defined under the Sarbanes-Oxley Act of 2002 and the rules
8-K
EX-1.1
u0kndt033w 5s
17 Feb 21
Hepion Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
8:06am
S-8
kbwfw1m6n9liqf
19 Jan 21
Registration of securities for employees
12:00am
8-K
EX-1.1
c9q3ko62x1wi3kykbx
27 Nov 20
Hepion Pharmaceuticals Prices Public Offering
1:48pm
8-K
EX-99.1
ce6njvt0ni9 xw
10 Jun 20
Hepion Pharmaceuticals Welcomes Industry Veteran and Drug Development Expert, Dr. Peter Wijngaard, to its Board of Directors
5:04pm
8-K
EX-5.1
04y7d8xv44otr
27 Mar 20
Other Events
12:53pm
8-K
EX-5.1
ijy5nvtk0o4uzu0r
12 Feb 20
Entry into a Material Definitive Agreement
4:55pm
8-K
npvlbjk p5veachv63
6 Jan 20
Hepion Pharmaceuticals Announces Publication inExpert Opinion on Investigational Drugs
4:23pm